Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey
dc.authorid | Paydas, Semra/0000-0003-4642-3693 | |
dc.authorid | Gokmen, Erhan/0000-0003-4596-2986 | |
dc.authorid | alan, ozkan/0000-0002-6635-2012 | |
dc.authorid | Eralp, Yesim/0000-0001-9603-4755 | |
dc.authorid | Tanriverdi, Ozgur/0000-0002-0598-7284 | |
dc.authorwosid | Basaran, Gul Atalay/AAT-7780-2020 | |
dc.authorwosid | Gokmen, Erhan/HKM-3785-2023 | |
dc.authorwosid | Paydas, Semra/F-3132-2018 | |
dc.authorwosid | Gokmen, Erhan/HKE-3549-2023 | |
dc.authorwosid | alan, ozkan/AAV-5044-2020 | |
dc.authorwosid | Eralp, Yesim/AAD-7194-2020 | |
dc.authorwosid | Tanriverdi, Ozgur/M-2172-2015 | |
dc.contributor.author | Demirci, Umut | |
dc.contributor.author | Gokmen, Erhan | |
dc.contributor.author | Eralp, Yesim | |
dc.contributor.author | Gunduz, Seyda | |
dc.contributor.author | Goksu, Sema Sezgin | |
dc.contributor.author | Korkmaz, Taner | |
dc.contributor.author | Kostek, Osman | |
dc.date.accessioned | 2024-06-12T11:21:00Z | |
dc.date.available | 2024-06-12T11:21:00Z | |
dc.date.issued | 2020 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description | 42nd Annual San Antonio Breast Cancer Symposium -- DEC 09-14, 2019 -- San Antonio, TX | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.identifier.doi | 10.1158/1538-7445.SABCS19-P5-11-19 | |
dc.identifier.issn | 0008-5472 | |
dc.identifier.issn | 1538-7445 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.uri | https://doi.org/10.1158/1538-7445.SABCS19-P5-11-19 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/25881 | |
dc.identifier.volume | 80 | en_US |
dc.identifier.wos | WOS:000527012503011 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Assoc Cancer Research | en_US |
dc.relation.ispartof | Cancer Research | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey | en_US |
dc.type | Conference Object | en_US |